| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/11/2010 | CA2366231C One step sample preparation and detection of nucleic acids in complex biological samples |
| 05/11/2010 | CA2341638C Use of a midkine inhibitor |
| 05/11/2010 | CA2330735C Fy7 polymerase |
| 05/11/2010 | CA2326401C Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 05/11/2010 | CA2165297C Myeloid cell leukemia associated gene mcl-1 |
| 05/11/2010 | CA2122365C Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines |
| 05/07/2010 | CA2684809A1 Medium for detecting and differentiating vancomycin-resistant enterococci |
| 05/06/2010 | WO2010051550A1 Methods of diagnosing and treating fibrosis |
| 05/06/2010 | WO2010051464A1 Methods of determining copy number of a genetic locus |
| 05/06/2010 | WO2010051343A1 Photoreactive synthetic regulator of protein function and methods of use thereof |
| 05/06/2010 | WO2010051261A2 A genetic marker for detection of human papillomavirus |
| 05/06/2010 | WO2010051252A1 A flow-through thermal cycling device |
| 05/06/2010 | WO2010051215A1 Methods for making hiv vaccines and related compositions |
| 05/06/2010 | WO2010051214A1 Compositions and methods for detecting mutations in jak2 nucleic acid |
| 05/06/2010 | WO2010051204A2 Bcr-abl variants |
| 05/06/2010 | WO2010051055A2 Detection of spiroplasmosis and transmissible spongiform encephalopathies |
| 05/06/2010 | WO2010050898A1 Device and method for detection of analyte from a sample |
| 05/06/2010 | WO2010050829A1 Marker assisted selection of a mammalian subject for desired immunoglobulin phenotype |
| 05/06/2010 | WO2010050584A1 Method for selectively controlling function of helper t cell |
| 05/06/2010 | WO2010050418A1 Mutant reverse transcription dna polymerase |
| 05/06/2010 | WO2010050328A1 Tumor metastasis inhibitor |
| 05/06/2010 | WO2010050268A1 Molecular marker for cancer stem cell |
| 05/06/2010 | WO2010050190A1 Molecular marker for cancer stem cell |
| 05/06/2010 | WO2010050167A1 Composition for inducing th2 cell, therapeutic composition for th2-type disease, and use of same |
| 05/06/2010 | WO2010049816A2 Ubiquitin specific proteases responsible for mcl-1 stability and uses thereof |
| 05/06/2010 | WO2010049665A2 A method |
| 05/06/2010 | WO2010049590A2 A new pharmaceutical product |
| 05/06/2010 | WO2010049489A1 Method for fast detection and identification of micro-organisms |
| 05/06/2010 | WO2010049450A1 Non-hydrolytic microbial probes |
| 05/06/2010 | WO2010049430A1 Device and method for analysing cells |
| 05/06/2010 | WO2010049373A2 Method for distinguishing between the species coffea arabica and coffea canephora and hybrids thereof based on the concomitant analysis of nuclear and chloroplastic dna polymorphisms. |
| 05/06/2010 | WO2010049156A1 Sequencing of nucleic acid molecules by mass spectrometry |
| 05/06/2010 | WO2010048976A1 NITROREDUCTASE NfnB FROM MYCOBACTERIUM SMEGMATIS |
| 05/06/2010 | WO2010048710A1 Neurotoxic sterol glycosides |
| 05/06/2010 | WO2010048691A1 Multiplex genotyping assay for detecting mutations in k-ras |
| 05/06/2010 | WO2010033818A8 Mirna targets |
| 05/06/2010 | WO2010030167A3 Method of detection and diagnosis of oral and nasopharyngeal cancers |
| 05/06/2010 | WO2010029174A3 Method for classifying a cancer patient as responder or non-responder to immunotherapy |
| 05/06/2010 | WO2010028999A3 Production of infectious hepatitis c virus particles in cell culture |
| 05/06/2010 | WO2010016064A3 Gene expression signature for classification of kidney tumors |
| 05/06/2010 | WO2010014975A3 Use of microrna signatures for assessing risk levels of neuroblastoma patients |
| 05/06/2010 | WO2010014820A3 Particles for use in supported nucleic acid ligation and detection sequencing |
| 05/06/2010 | WO2010014740A3 Eg82013 and eg81345 nucleic acids and uses thereof |
| 05/06/2010 | WO2010013038A3 Novel methods of differentiating yeast strains and/or determining genetic stability of yeast strains, and uses thereof |
| 05/06/2010 | WO2010011884A3 Novel nucleic acid-based molecular probes |
| 05/06/2010 | WO2010011642A3 Methods and compositions using splicing regulatory proteins involved in tumor suppression |
| 05/06/2010 | WO2010011304A3 Crystal structure of bifunctional transglycosylase pbp1b from e.coli and inhibitors thereof |
| 05/06/2010 | WO2010011242A3 Methods and compositions for the treatment and diagnoisis of systemic anthrax infection |
| 05/06/2010 | WO2010009074A3 Method for predicting and detecting tumor metastasis |
| 05/06/2010 | WO2010002895A3 Lysosomal phospholipase a2 (lpla2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis |
| 05/06/2010 | WO2009158006A3 Methods and apparatus for detecting molecular interactions using fet arrays |
| 05/06/2010 | WO2009134452A3 Preterm delivery diagnostic assay |
| 05/06/2010 | WO2009108745A8 Structure of a protein phosphatase 2a holoenzyme: insights into tau dephosphorylation |
| 05/06/2010 | WO2009044152A8 Genetic test for liver copper accumulation in dogs and low copper pet diet |
| 05/06/2010 | US20100115669 Plant Cyclopropane Fatty Acid Synthase Genes, Proteins, And Uses Thereof |
| 05/06/2010 | US20100115663 Acetyl-CoA Carboxylase Herbicide Resistant Sorghum |
| 05/06/2010 | US20100115654 Insect resistant plant |
| 05/06/2010 | US20100115650 Herbicide-Resistant Brassica Plants and Methods of Use |
| 05/06/2010 | US20100115642 Xenogenic immune system in a non-human mammal |
| 05/06/2010 | US20100115635 Methods for Assessing the Delivery of Exogenous Agents |
| 05/06/2010 | US20100114956 System and method for inferring str allelic genotype from snps |
| 05/06/2010 | US20100114500 Analysis of dna |
| 05/06/2010 | US20100113759 Propargyl substituted nucleoside compounds and methods |
| 05/06/2010 | US20100113745 Means and Methods for Influencing the Stability of Antibody Producing Cells |
| 05/06/2010 | US20100113577 Isolated nucleic acid molecules corresponding to micro rna 145 (mirna-145) and their use in treating colon cancer |
| 05/06/2010 | US20100113575 Method for detecting autoprocessed, secreted pcsk9 |
| 05/06/2010 | US20100113568 Methods for binding lewis y antigen |
| 05/06/2010 | US20100113562 Therapeutic targets and molecules |
| 05/06/2010 | US20100113561 Microrna molecules |
| 05/06/2010 | US20100113557 Method for prevention of tumor |
| 05/06/2010 | US20100113553 Methods of using proteinacious channels to identify pharmaceutical treatments and risks, and treatments resulting therefrom |
| 05/06/2010 | US20100113508 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator |
| 05/06/2010 | US20100113486 Use of pde7 inhibitors for the treatment of movement disorders |
| 05/06/2010 | US20100113477 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof |
| 05/06/2010 | US20100113470 Bcr-abl variants |
| 05/06/2010 | US20100113459 Gene Polymorphisms as Predictors of Tumor Progression and Their Use in Cancer Therapy |
| 05/06/2010 | US20100113379 cAMP DEPENDENT INDUCTION OF AUTOPHAGY |
| 05/06/2010 | US20100113358 Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta |
| 05/06/2010 | US20100113344 Method Of Detection Of Nucleic Acids With A Specific Sequence Composition |
| 05/06/2010 | US20100113343 Methods involving lef-1 regulation and use of lef-1 or compounds altering lef-1 signalling for treating or preventing diseases |
| 05/06/2010 | US20100113340 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof |
| 05/06/2010 | US20100113327 Methods for controlling mineralization of extracellular matrix, therapeutic methods based thereon and medicaments for use therein |
| 05/06/2010 | US20100113303 Polypeptide Display Libraries and Methods of Making and Using Thereof |
| 05/06/2010 | US20100113301 Method for the identification and/or the quantification of a target compound obtained from a biological sample upon chips |
| 05/06/2010 | US20100113299 Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type |
| 05/06/2010 | US20100113298 Detection of rna with micro-arrays |
| 05/06/2010 | US20100113297 Method for predicting the occurrence of metastasis in breast cancer patients |
| 05/06/2010 | US20100113292 Methods of obtaining active antisense compounds |
| 05/06/2010 | US20100113290 Methods for assessing rna patterns |
| 05/06/2010 | US20100113288 Modular System for Performing Laboratory Protocols and Associated Methods |
| 05/06/2010 | US20100113286 Methods for detection of preeclampsia |
| 05/06/2010 | US20100113285 Normalization of Data Using Controls |
| 05/06/2010 | US20100113284 Small interfering rna (sirna) target site blocking oligos and uses thereof |
| 05/06/2010 | US20100112708 Methods and Mixtures Pertaining to Analyte Determination Using Electrophilic Labeling Reagents |
| 05/06/2010 | US20100112705 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
| 05/06/2010 | US20100112666 Dehalogenases, Nucleic Acids Encoding Them and Methods for Making and Using Them |
| 05/06/2010 | US20100112635 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 05/06/2010 | US20100112631 Chip Having Microchannel For Counting Specific Micro Particles Among Floating Micro Particle Mixture By Optical Means And A Method For Counting Micro Particles Using The Same |
| 05/06/2010 | US20100112630 Methods for measuring microbiological content in aqueous media |
| 05/06/2010 | US20100112629 Cell block cassette device |